Đang chuẩn bị liên kết để tải về tài liệu:
Comparing the performance of selected variant callers using synthetic data and genome segmentation
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
High-throughput sequencing has rapidly become an essential part of precision cancer medicine. But validating results obtained from analyzing and interpreting genomic data remains a rate-limiting factor. The gold standard, of course, remains manual validation by expert panels, which is not without its weaknesses, namely high costs in both funding and time as well as the necessarily selective nature of manual validation. |